"Proposed Bill Aims to Tackle Obesity Epidemic with Medicare Coverage for Weight-Loss Drugs"

Lawmakers have reintroduced a bill called The Treat and Reduce Obesity Act of 2023, which aims to expand Medicare coverage to weight-loss drugs like Wegovy. Currently, Medicare is prohibited from paying for such medications. The bill faces challenges due to the high cost of weight-loss treatment, but if passed, it could have implications for other health insurers as well. With obesity rates on the rise, advocates argue that obesity should be treated like any other chronic disease. Drugmakers like Novo Nordisk and Eli Lilly, who have seen increased demand for their weight-loss medications, are lobbying for Medicare coverage expansion.